by Brian McNaughton | Apr 16, 2024 | Brian McNaughton, Professional Overview
In medical science, RNA-targeted therapies have emerged as a beacon of hope for individuals battling rare genetic disorders. These groundbreaking treatments offer a ray of light for conditions that were once considered untreatable. Let’s delve into the progress...
by Brian McNaughton | Mar 15, 2024 | Brian McNaughton, Professional Overview
In medical advancements, RNA-targeted therapies have emerged as a promising avenue for tackling neurodegenerative diseases. These conditions, such as Alzheimer’s, Parkinson’s, and Huntington’s disease, pose significant challenges to patients and...
by Brian McNaughton | Jan 22, 2024 | Brian McNaughton, Professional Overview
In the realm of modern medicine, precision is paramount. As researchers delve deeper into the intricacies of diseases and therapeutic interventions, a powerful tool has emerged to revolutionize the landscape: nanobody engineering. Nanobodies, derived from the unique...
by Brian McNaughton | Dec 18, 2023 | Professional Overview, Brian McNaughton
Neurodegenerative diseases pose a formidable challenge to medical science, affecting millions worldwide and causing profound disruptions to the lives of patients and their families. Among the promising avenues of research and treatment, RNA-targeted approaches have...
by Brian McNaughton | Nov 6, 2023 | Brian McNaughton, Professional Overview
In the rapidly evolving landscape of drug discovery and development, peptide-based drugs have gained considerable attention for their potential to treat a wide range of diseases, offering enhanced specificity and reduced side effects. This class of drugs, known as...
